BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 5, 2009
View Archived Issues
Trabectedin beneficial in some castration-resistant prostate cancer patients
Read More
Optimer to file MAA with EMEA for fidaxomicin in CDI
Read More
Novel EGFR inhibitors discovered by Astellas researchers
Read More
AstraZeneca discloses new mTOR inhibitors
Read More
New SCD inhibitors for obesity imparted in recent GSK patent
Read More
Schering-Plough imparts new HCV NS3/NS4 protease inhibitors
Read More
Sonexa Therapeutics evaluates efficacy and safety of ST-101 in Alzheimer's disease
Read More
Darifenacin reduces incontinence in overactive bladder patients
Read More
2008 highlights at Chugai
Read More
Nabriva Therapeutics claims new pleuromutilin derivatives as antimicrobials
Read More
Gemin X initiates phase II obatoclax trial in combination with chemotherapy
Read More
FDA approves Copaxone for patients with a first clinical event of MS
Read More
AZD-4877 shows antitumor activity in human bladder cancer models
Read More
AV-951 shows activity in phase II trial for renal cell carcinoma
Read More
Immunomodulation via Toll-like receptors may be beneficial in Alzheimer's disease
Read More
Boston Scientific launches Taxus Liberte paclitaxel-eluting stent in Japan
Read More
First patient treated in novel immunotherapeutic vaccine trial
Read More
EyeGate completes phase II EGP-437 trial for dry eye syndrome
Read More
FDA accepts IND application for Tigris Pharmaceutical's GGTI-2418
Read More
FDA clears Cellectar's IND application for 131I-CLR1404
Read More
Serentis initiates phase II trial of SRD-174 for pruritus in atopic dermatitis patients
Read More
Xoma initiates phase IIa XOMA-052 trial in patients with rheumatoid arthritis
Read More
Enobia completes enrollment in clinical trial of ENB-0040 in infantile hypophosphatasia
Read More
FDA removes clinical hold from Aastrom's phase II IMPACT-DCM trial
Read More
Acura's NDA for Acurox accepted by FDA for filing with priority review
Read More
Menarini launches CV Therapeutics' Ranexa in the U.K. and Germany
Read More